245 related articles for article (PubMed ID: 36702900)
41. Parallel engineering and activity profiling of a base editor system.
Fong JHC; Chu HY; Zhou P; Wong ASL
Cell Syst; 2023 May; 14(5):392-403.e4. PubMed ID: 37164010
[TBL] [Abstract][Full Text] [Related]
42. CRISPR-Cas12a-Mediated Gene Deletion and Regulation in
Zhao R; Liu Y; Zhang H; Chai C; Wang J; Jiang W; Gu Y
ACS Synth Biol; 2019 Oct; 8(10):2270-2279. PubMed ID: 31526005
[TBL] [Abstract][Full Text] [Related]
43. Review: Sustainable Clinical Development of CAR-T Cells - Switching From Viral Transduction Towards CRISPR-Cas Gene Editing.
Wagner DL; Koehl U; Chmielewski M; Scheid C; Stripecke R
Front Immunol; 2022; 13():865424. PubMed ID: 35784280
[TBL] [Abstract][Full Text] [Related]
44. The Conspicuity of CRISPR-Cpf1 System as a Significant Breakthrough in Genome Editing.
Bayat H; Modarressi MH; Rahimpour A
Curr Microbiol; 2018 Jan; 75(1):107-115. PubMed ID: 29189942
[TBL] [Abstract][Full Text] [Related]
45. CRISPR/Cas12a-Mediated Genome Editing in
Hao X; Mu T; Sharshar MM; Jia Y; Zhong W; Chen Z; Wen Q; Yang M; Wang C; Xing J
ACS Synth Biol; 2023 Apr; 12(4):1204-1215. PubMed ID: 37017652
[TBL] [Abstract][Full Text] [Related]
46. CAMERS-B: CRISPR/Cpf1 assisted multiple-genes editing and regulation system for Bacillus subtilis.
Wu Y; Liu Y; Lv X; Li J; Du G; Liu L
Biotechnol Bioeng; 2020 Jun; 117(6):1817-1825. PubMed ID: 32129468
[TBL] [Abstract][Full Text] [Related]
47. Implementing CRISPR-Cas12a for Efficient Genome Editing in Yarrowia lipolytica.
Yang Z; Xu P
Methods Mol Biol; 2021; 2307():111-121. PubMed ID: 33847985
[TBL] [Abstract][Full Text] [Related]
48. Recent advances of Cas12a applications in bacteria.
Meliawati M; Schilling C; Schmid J
Appl Microbiol Biotechnol; 2021 Apr; 105(8):2981-2990. PubMed ID: 33754170
[TBL] [Abstract][Full Text] [Related]
49. CRISPR/Cpf1-mediated mutagenesis and gene deletion in industrial filamentous fungi Aspergillus oryzae and Aspergillus sojae.
Katayama T; Maruyama JI
J Biosci Bioeng; 2022 Apr; 133(4):353-361. PubMed ID: 35101371
[TBL] [Abstract][Full Text] [Related]
50. Expanding the Potential of CRISPR-Cpf1-Based Genome Editing Technology in the Cyanobacterium Anabaena PCC 7120.
Niu TC; Lin GM; Xie LR; Wang ZQ; Xing WY; Zhang JY; Zhang CC
ACS Synth Biol; 2019 Jan; 8(1):170-180. PubMed ID: 30525474
[TBL] [Abstract][Full Text] [Related]
51. Directed Evolution of CRISPR/Cas Systems for Precise Gene Editing.
Liu R; Liang L; Freed EF; Gill RT
Trends Biotechnol; 2021 Mar; 39(3):262-273. PubMed ID: 32828556
[TBL] [Abstract][Full Text] [Related]
52. Genome modification of CXCR4 by Staphylococcus aureus Cas9 renders cells resistance to HIV-1 infection.
Wang Q; Chen S; Xiao Q; Liu Z; Liu S; Hou P; Zhou L; Hou W; Ho W; Li C; Wu L; Guo D
Retrovirology; 2017 Nov; 14(1):51. PubMed ID: 29141633
[TBL] [Abstract][Full Text] [Related]
53. Single-Base Genome Editing in
Kim HJ; Oh SY; Lee SJ
J Microbiol Biotechnol; 2020 Oct; 30(10):1583-1591. PubMed ID: 32807756
[TBL] [Abstract][Full Text] [Related]
54. Engineering of CRISPR-Cas12b for human genome editing.
Strecker J; Jones S; Koopal B; Schmid-Burgk J; Zetsche B; Gao L; Makarova KS; Koonin EV; Zhang F
Nat Commun; 2019 Jan; 10(1):212. PubMed ID: 30670702
[TBL] [Abstract][Full Text] [Related]
55. Portable CRISPR-Cas9
Goh YJ; Barrangou R
Appl Environ Microbiol; 2021 Feb; 87(6):. PubMed ID: 33397707
[TBL] [Abstract][Full Text] [Related]
56. Targeted activation of diverse CRISPR-Cas systems for mammalian genome editing via proximal CRISPR targeting.
Chen F; Ding X; Feng Y; Seebeck T; Jiang Y; Davis GD
Nat Commun; 2017 Apr; 8():14958. PubMed ID: 28387220
[TBL] [Abstract][Full Text] [Related]
57. Engineering T Cells Using CRISPR/Cas9 for Cancer Therapy.
Zhang X; Cheng C; Sun W; Wang H
Methods Mol Biol; 2020; 2115():419-433. PubMed ID: 32006414
[TBL] [Abstract][Full Text] [Related]
58. Efficient CRISPR/Cas9 genome editing with low off-target effects in zebrafish.
Hruscha A; Krawitz P; Rechenberg A; Heinrich V; Hecht J; Haass C; Schmid B
Development; 2013 Dec; 140(24):4982-7. PubMed ID: 24257628
[TBL] [Abstract][Full Text] [Related]
59. Ribonucleoprotein Transfection for CRISPR/Cas9-Mediated Gene Knockout in Primary T Cells.
Oh SA; Seki A; Rutz S
Curr Protoc Immunol; 2019 Feb; 124(1):e69. PubMed ID: 30334617
[TBL] [Abstract][Full Text] [Related]
60. A Tet-Inducible CRISPR Platform for High-Fidelity Editing of Human Pluripotent Stem Cells.
Jurlina SL; Jones MK; Agarwal D; De La Toba DV; Kambli N; Su F; Martin HM; Anderson R; Wong RM; Seid J; Attaluri SV; Chow M; Wahlin KJ
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
